pyridostigmine bromide has been researched along with Heart Disease, Ischemic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, J; He, X; Liu, LZ; Yang, Y; Yu, XJ; Zang, WJ; Zhao, M | 1 |
Castro, RR; Nóbrega, AC; Porphirio, G; Serra, SM | 1 |
Castro, RR; Mendes, FS; Nóbrega, AC; Oliveira, LP; Porphirio, G; Serra, SM | 1 |
2 trial(s) available for pyridostigmine bromide and Heart Disease, Ischemic
Article | Year |
---|---|
Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Cholinesterase Inhibitors; Coronary Disease; Cross-Over Studies; Double-Blind Method; Exercise; Exercise Tolerance; Female; Heart Rate; Humans; Male; Myocardial Ischemia; Oxygen Consumption; Pyridostigmine Bromide | 2004 |
Pyridostigmine reduces QTc interval during recovery from maximal exercise in ischemic heart disease.
Topics: Administration, Oral; Aged; Cholinesterase Inhibitors; Exercise; Exercise Test; Exercise Tolerance; Female; Heart Conduction System; Humans; Male; Myocardial Ischemia; Pyridostigmine Bromide | 2006 |
1 other study(ies) available for pyridostigmine bromide and Heart Disease, Ischemic
Article | Year |
---|---|
Pyridostigmine regulates glucose metabolism and mitochondrial homeostasis to reduce myocardial vulnerability to injury in diabetic mice.
Topics: Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Glucose; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Myocardial Ischemia; Myocytes, Cardiac; Oxidative Stress; Pyridostigmine Bromide | 2019 |